Renaissance Capital’s Hinge Health HNGE Stock Holding History

Renaissance Capital’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.59M	Buy	+16,391	New	+$1.44M	1.1%	23

Other funds holding HNGE

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Renaissance Capital's HNGE Position: Q3 2026 in Review

Renaissance Capital opened a new position in Hinge Health (HNGE) in Q3 2026: 16,391 shares worth $1.59M. The stake represents 1.1% of the portfolio and ranks #23 among its holdings.

170 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

Renaissance Capital held 16,391 shares of Hinge Health worth $1.59M as of Q3 2026.
Hinge Health was a new Renaissance Capital position in Q3 2026.
Hinge Health made up 1.1% of Renaissance Capital's portfolio in Q3 2026, its #23 holding.
170 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on Renaissance Capital's 13F filing for Q3 2026, filed 23 Oct 2026.